medigraphic.com
ISSN 0016-3813 (Print)

2004, Number 2

<< Back Next >>

Gac Med Mex 2004; 140 (2)

Morbility at the Instituto Nacional de Neurología y Neurocirugia Manuel Velasco Suárez, 1995-2001.

Jiménez-Marcial ME, Velásquez-Pérez L

Language: Spanish
References: 41
Page: 155-162
PDF size: 453.24 Kb.


ABSTRACT

Hospital statistics are very important as tools that help to define research objectives and design health programs. Objective: to determine the main causes of hospital morbility at the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery (MVS-NINN) between 1995 and 2001. Material and Methods: data were taken from the electronic database of morbidity and mortality of MVS-NINN. All outpatient records between 1995 and 2001 were considered. We calculatedtrendsandspecificratesofmorbidityper100discharged patients. Results: the main causes of morbility were brain tumors, schizophrenic illness, neurocysticercosis, and stroke. We found a statistically significant declining time-trend of schizophrenic illness and in non-traumatic brain hemorrhage in males. In the case of females, we observed an increasing time-trend of benign meningeal tumors. The age groups more affected in both genders were those < 51 years of age. Conclusions: This study is not a population study, but it helps to increase knowledge of the main causes of hospitalization at one of the most important neurologic institutions in the world, which provides care for thinsured population throughout Mexico. These findings facilitate analysis and decision-making to undertake specificactions to improve the quality of neurologic medical attention.


REFERENCES

  1. Jenicek M. Valoración de la salud de los individuos y de las poblaciones. En: Jenicek M, editor. Epidemiología. La lógica de la medicina moderna. Barcelona, España: Masson; 1996. p 43-78.

  2. Matsumoto N, Whisnant JP. Natural history of stroke in Rochester, Minnesota. 1955-1969: an extension of a previous study, 1945 through 1954. Stroke 1973;4:20-29.

  3. Gillum RF, Feinleib M, Margokis Jr. Community surveillance for cardiovascular disease: the Framingham Cardiovascular Disease Survey. J Chronic Dis 1976;29:289-299.

  4. Thacker SB, Berkelman RL. Public health surveillance in the United States. Epidemiol Rev 1988;10:164-190.

  5. Roelands M, Wostyn P, Dom H, Baro F. The prevalence of dementia in Belgium: a population based door to door survey in a rural community. Neuroepidemiology 1994;14:155-161.

  6. Muñoz M, Boutros-Toni F, Preux PM, et al. Prevalence of neurological disorders in Haute-Vienne Department (Limousin Region-France). Neuroepidemiology 1995;14:193-198.

  7. Nakashima K, Yokohama Y, Shimoyama R, et al. Prevalence of neurological disorders in a Japanese town. Neuroepidemiology 1996;15:208-213.

  8. Cruz-Alcalá LE, Vázquez-Castellanos JL. Prevalencia de algunas enfermedades neurológicas en la Ciudad de Tepatitlán, Jalisco, México. Rev Mex Neuroci 2002;3:71-76

  9. Dirección General de Información y Evaluación del Desempeño, de la Secretaría de Salud. Estadística de egresos hospitalarios del sector público del Sistema Nacional de Salud, 2000. Salud Publica Mex 2002;44:158-187.

  10. Organización Panamericana de la Salud, Oficina Sanitaria Panamericana, Oficina Regional de la ORGANIZACIÓN MUNDIAL DE LA SALUD. CIE-10. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. 10a rev. Vol. 1. Ginebra, Suiza: OMS; 1992.

  11. Daly LE, Bourke GJ, McGilvray J. Vital statistics. In: Daly LE, Bourke GJ, McGilvray J, editors. Interpretation and uses of medical statistics. Oxford, Blackwell Scientific Publications; UK: 1991. p. 266-287.

  12. Altman DG. Relation between two continuous variables. In: Practical Statistics for medical research. London: Chapman & Hall, Inc; 1991. p. 277-325.

  13. Stata Corporation. Stata 5.0. College Station, TX, USA: Stata Corporation, 1997.

  14. Casabella B, Aguilar M, Jauma S. La patología neurológica extrahospitalaria: una visión clínico-asistencial de la demanda atendida por el neuropsiquiatra y el médico general. Rev Neurol 1990;93:197-202.

  15. Luengo A, Parra J, Fernández MJ, et al. Interrelación entre atención primaria y asistencia neurológica. Rev Neurol 1996;24:69-72.

  16. Ramírez L, Lara H. Estudio epidemiológico de padecimientos neurológicos dentro de un sistema de seguridad social (ISSSTE). Salud Publica Mex 1976;18:673-683.

  17. Olivares L. La epidemiología neurológica en México. Salud Publica Mex 1976;18:665-672.

  18. Hernández R, Fernández JA, Rancaño I, Cueto A. Calidad de vida y enfermedades neurológicas. Neurología 2001;16:30-37.

  19. Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990;82:1621-1624.

  20. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991;19:421-431

  21. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-1308.

  22. Radhakrishnan K, Mokri B, Parisi JE, O’Fallon WM, Sunku J, Kurland LT. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995;37:67-73.

  23. Desmeules M, Mikkelsen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 1992;84:442-445.

  24. Percy AK, Elveback LR, Okazaki H, et al. Neoplasms of the central nervous system. Neurology 1972;22:40-48.

  25. Gurney JG, Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001;13:160-166.

  26. Gurney JG, Davis S, Severson RK, et al. Trends in cancer incidence among children in the US. Cancer 1996;78:532-541.

  27. Smith M, Freidlin B. Ries L, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998;90:1269-1277.

  28. Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly. Arch Neurol 1998;55:922-928.

  29. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996;29:197-205.

  30. Bresnahan MA, Brown AS, Schaefer CA, Begg MD, Wyatt RJ, Susser ES. Incidence and cumulative risk of the Treated Schizophrenia in the Prenatal Determinants of Schizophrenia Study. Schizophrenia Bull 2000;26:297-308.

  31. Der G, Gupta S, Murray R. Is schizophrennia disappearing? Lancet 1990;335:513-516.

  32. Suvisaari JM, Haukka JK, Tanskanen AJ, Lonnqvist JK. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch Gen Psychiatry 1999;56:733-740.

  33. Trastornos bipolares. En: DMS-IV-TR. Manual diagnóstico y estadístico de los trastornos mentales. Texto Revisado. Barcelona, España: Masson; 2002. p. 428-444.

  34. Perkin GD. An analysis of 7836 successive new outpatient referrals. J Neurol Neurosurg Psychiatry 1991;54:447-448.

  35. Villagra P, Cubero A. Estudio de la demanda asistencial en una consulta jerarquizada de Neurología correspondiente al área Norte de las Palmas de Gran Canaria. Rev Neurol 1997;25:1544-1546.

  36. Cantú B, Talamás O, Mejía A, et al. Prevención primaria de la enfermedad vascular cerebral. Rev Invest Clin 2002;54:247-256.

  37. Gracia NM, Marta E, Carod J, et al. Consideraciones acerca de una consulta externa de Neurología. Rev Neurol 1994;22:316-317.

  38. Pascual J, Berciano J. Estudio epidemiológico de los brotes de migraña. Neurología 1988;3(Suppl 3):17.

  39. Pondal M, del Ser T, Bermejo F. La asistencia neurológica ambulatoria extrahospitalaria. Análisis de la demanda registrada durante 18 meses en una consulta jerarquizada de Neurología. Neurología 1989;4:124-131.

  40. Delgado JM, Martín R, Matías-Guiu J. La concordancia diagnóstica en la Neurología de distrito. Rev Neurol 1994;22:20-26.

  41. Antigüedad A, Bárcena J, Pérez Bas M, et al. Actividad asistencial de los facultativos de área en Neurología; experiencia en Vizcaya. Neurología 1995;10:324-329.




2020     |     www.medigraphic.com